Jpmorgan Chase & CO Zynex Inc Transaction History
Jpmorgan Chase & CO
- $1.27 Trillion
- Q1 2025
A detailed history of Jpmorgan Chase & CO transactions in Zynex Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 93,995 shares of ZYXI stock, worth $234,047. This represents 0.0% of its overall portfolio holdings.
Number of Shares
93,995
Previous 42,997
118.61%
Holding current value
$234,047
Previous $344,000
40.12%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding ZYXI
# of Institutions
89Shares Held
6.27MCall Options Held
7KPut Options Held
15.1K-
Black Rock Inc. New York, NY1.24MShares$3.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.05MShares$2.61 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT488KShares$1.21 Million0.05% of portfolio
-
Geode Capital Management, LLC Boston, MA387KShares$963,6220.0% of portfolio
-
State Street Corp Boston, MA361KShares$897,7090.0% of portfolio
About ZYNEX INC
- Ticker ZYXI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Distribution
- Shares Outstandng 37,453,400
- Market Cap $93.3M
- Description
- Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and n...